Published in Virchows Arch on April 03, 2015
Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg (1986) 5.85
Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg (1974) 2.30
Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg (1997) 2.00
Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (2003) 1.95
The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys (2005) 1.38
Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys (2006) 1.37
Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck (2010) 1.20
Salivary gland cancer in Finland 1991--96: an evaluation of 237 cases. Acta Otolaryngol (2005) 1.13
Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer (2011) 1.13
High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg (2003) 1.12
Biology and management of salivary gland cancers. Semin Radiat Oncol (2012) 1.09
Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. Oral Oncol (2013) 1.05
Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol (2012) 1.04
Salivary gland adenoid cystic carcinoma with cervical lymph node metastasis: a preliminary study of 62 cases. Int J Oral Maxillofac Surg (2012) 0.99
Adenoid cystic carcinoma of the head and neck: clinicopathologic analysis of 218 cases in a Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.92
Treatment of malignant tumors in the parotid glands. Cancer (1990) 0.88
Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: a single institutional experience at a tertiary care center. Head Neck (2014) 0.86
Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study. Head Neck (2013) 0.82
Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma. Head Neck (2014) 0.82
Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neck. Laryngoscope (2013) 0.81
Adenoid cystic carcinoma of parotid gland treated with surgery and radiotherapy: long-term outcomes, QoL assessment and review of the literature. Oral Oncol (2011) 0.79
Facial nerve sacrifice and radiotherapy in parotid adenoid cystic carcinoma. Laryngoscope (2008) 0.78
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol (2010) 4.26
Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer (2006) 2.03
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer (2003) 1.57
Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol (2011) 1.53
Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol (2005) 1.42
Cystic neck lesions: clinical, radiological and differential diagnostic considerations. Acta Otolaryngol (2010) 1.32
High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer (2008) 1.30
Central adenoid cystic carcinoma of the mandible: case report and literature review of 16 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.15
Salivary gland cancer in Finland 1991--96: an evaluation of 237 cases. Acta Otolaryngol (2005) 1.13
Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol (2009) 1.12
Histopathological findings in parotid gland metastases from renal cell carcinoma. Eur Arch Otorhinolaryngol (2008) 1.07
Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck (2013) 1.07
Management and outcome of salivary duct carcinoma in major salivary glands. Eur Arch Otorhinolaryngol (2012) 1.06
The changing surgical management of juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol (2010) 1.06
Fungal infection of the epiglottis simulating a clinical malignancy. Arch Otolaryngol Head Neck Surg (2003) 1.03
Recent advances in the diagnostic pathology of salivary carcinomas. Virchows Arch (2014) 1.02
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys (2011) 1.01
Podocalyxin is a marker of poor prognosis in colorectal cancer. BMC Cancer (2014) 0.99
Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol (2010) 0.99
Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol (2007) 0.99
Laryngeal fractures: clinical findings and considerations on suboptimal outcome. Acta Otolaryngol (2008) 0.99
Hypopharyngeal carcinoma in Finland from 1990-1999. Eur Arch Otorhinolaryngol (2004) 0.98
Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol (2005) 0.97
Does septoplasty enhance the quality of life in patients? Eur Arch Otorhinolaryngol (2012) 0.97
CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther (2012) 0.97
Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses. Virchows Arch (2011) 0.96
Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol (2012) 0.96
Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol (2007) 0.95
MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol (2010) 0.95
Pharyngocutaneous fistula following total laryngectomy: a single institution's 10-year experience. Eur Arch Otorhinolaryngol (2006) 0.95
Quality of life after free-flap reconstruction in patients with oral and pharyngeal cancer. Head Neck (2006) 0.93
Otologic consequences of blast exposure: a Finnish case study of a shopping mall bomb explosion. Acta Otolaryngol (2004) 0.93
Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience. Laryngoscope (2008) 0.91
Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume. Radiother Oncol (2011) 0.91
Computerized tomography findings and recurrence of keratocystic odontogenic tumor of the mandible and maxillofacial region in a series of 46 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.91
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch (2015) 0.91
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma. Head Neck (2014) 0.90
Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer. Radiother Oncol (2008) 0.89
Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol (2006) 0.88
A comparative study of two PODXL antibodies in 840 colorectal cancer patients. BMC Cancer (2014) 0.88
Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome. Thyroid (2013) 0.88
Radiofrequency induced thermotherapy: an alternative palliative treatment modality in head and neck cancer. Eur Arch Otorhinolaryngol (2006) 0.87
Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med (2011) 0.87
Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res (2003) 0.87
Hamartoma of the larynx: an unusual cause of dyspnea. Ann Otol Rhinol Laryngol (2003) 0.86
Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol (2010) 0.86
Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. Laryngoscope (2012) 0.86
Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med (2012) 0.85
Experience of head and neck extracranial schwannomas in a whole population-based single-center patient series. Eur Arch Otorhinolaryngol (2014) 0.85
Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet (2002) 0.85
L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. Int J Radiat Oncol Biol Phys (2011) 0.85
Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol (2007) 0.84
Management of facial nerve schwannoma: A single institution experience. Acta Otolaryngol (2010) 0.84
Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol (2010) 0.84
Sentinel lymph node biopsy as an alternative to wait and see policy in patients with small T1 oral cavity squamous cell carcinoma. Acta Otolaryngol (2008) 0.84
Radiofrequency ablation in advanced head and neck cancer. Eur Arch Otorhinolaryngol (2013) 0.84
Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role? Virchows Arch (2010) 0.83
Acute dysphagia associated with aortic dissection: a case report and review of the literature. Acta Otolaryngol (2010) 0.83
Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep (2006) 0.83
The developing management of esthesioneuroblastoma: a single institution experience. Eur Arch Otorhinolaryngol (2011) 0.83
Plasminogen activators and their inhibitors in human saliva and salivary gland tissue. Eur J Oral Sci (2006) 0.83
Postlaryngectomy voice restoration using a voice prosthesis: a single institution's ten-year experience. Ann Otol Rhinol Laryngol (2003) 0.83
Radiofrequency surgery of the soft palate in the treatment of mild obstructive sleep apnea is not effective as a single-stage procedure: A randomized single-blinded placebo-controlled trial. Laryngoscope (2009) 0.82
Bilateral Basal cell adenocarcinoma of the parotid gland: in a recipient of kidney transplant. Clin Med Insights Pathol (2010) 0.82
Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer. Acta Oncol (2011) 0.82